Schear Investment Advisers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Schear Investment Advisers's LLY Position: Q2 2026 in Review
Schear Investment Advisers increased its Eli Lilly (LLY) stake by 2.4% in Q2 2026, buying an estimated $171K and bringing the position to 7,178 shares worth $8.61M. The position accounts for 2.88% of the portfolio, ranked #7.
Schear Investment Advisers first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Schear Investment Advisers held 7,178 shares of Eli Lilly worth $8.61M as of Q2 2026.
- Schear Investment Advisers bought 167 Eli Lilly shares in Q2 2026, an estimated $171K.
- Eli Lilly made up 2.88% of Schear Investment Advisers's portfolio in Q2 2026, its #7 holding.
- Schear Investment Advisers first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
- 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Schear Investment Advisers's 13F filing for Q2 2026, filed 27 Jul 2026.